Table 1: Concordance of IgM titer results obtained by CTT (1+ strength as end point) with pre-DTT and post DTT treatment results obtained by CAT (1+/2+/3+ strength as end point).
|
|
Identical to CTT (1+) [%(n)] |
Less than CTT (1+) [%(n)] |
More than CTT (1+) [%(n)] |
|
IgM |
|||
|
pCAT (1+) |
|
|
|
|
Anti-A |
24.2 (477) |
48.7 (959) |
27.1 (533) |
|
Anti-B |
30.2 (591) |
39.8 (779) |
30.0 (586) |
|
pCAT (2+) |
|
|
|
|
Anti-A |
15.4 (308) |
77.8 (1555) |
6.8 (135) |
|
Anti-B |
14.8 (294) |
77.5 (1540) |
7.7 (154) |
|
pCAT (3+) |
|
|
|
|
Anti-A |
3.5 (66) |
96.5 (1810) |
0 (0) |
|
Anti-B |
0.8 (16) |
97.4 (1847) |
1.7 (33) |
|
CAT (1+) |
|
|
|
|
Anti-A |
17.6 (352) |
9 (181) |
73.4 (1472) |
|
Anti-B |
11.8 (237) |
6.5 (131) |
81.6 (1637) |
|
CAT (2+) |
|
|
|
|
Anti-A |
43.4 (870) |
36.6 (734) |
20 (401) |
|
Anti-B |
43.6 (875) |
25.1 (503) |
31.3 (627) |
|
CAT (3+) |
|
|
|
|
Anti-A |
7 (138) |
92 (1824) |
0 (0) |
|
Anti-B |
10.4 (208) |
86.9 (1736) |
2.7 (54) |
CAT: Pre DTT treatment; pCAT: Post DTT treatment